COVID-19 Associated Mucormycosis:: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic

Vinay Chamola; Rasoul Mohammadi; Harish Nair; Adit Goyal; Aarya Patel; Vikas Hassija; Matteo Bassetti; Pratik Narang; Roger Paredes; Jose R Santos; Seyed Jamal Hashemi; Mahnaz Pejman Sani; Kiana Shirani; Neda Alijani; Bahareh Abtahi Naeini; Mohsen Pourazizi; Seyed Hamidreza Abtahi; Farzin Khorvash; Mahdi Khanjari; Kazem Ahmadikia

doi:10.4103/jrms.jrms_1090_21

COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic

Vinay Chamola, Rasoul Mohammadi^*, Harish Nair, Adit Goyal, Aarya Patel, Vikas Hassija, Matteo Bassetti, Pratik Narang, Roger Paredes, Jose R Santos, Seyed Jamal Hashemi, Mahnaz Pejman Sani, Kiana Shirani, Neda Alijani, Bahareh Abtahi Naeini, Mohsen Pourazizi, Seyed Hamidreza Abtahi, Farzin Khorvash, Mahdi Khanjari, Kazem Ahmadikia

^*Corresponding author for this work

Usher Institute

Research output: Contribution to journal › Article › peer-review

Abstract

At a time when the COVID-19’s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.

Original language	English
Article number	57
Pages (from-to)	57
Journal	Journal of Research in Medical Sciences
Volume	27
DOIs	https://doi.org/10.4103/jrms.jrms_1090_21
Publication status	Published - 29 Jul 2022

Access to Document

10.4103/jrms.jrms_1090_21Licence: Creative Commons: Attribution-NonCommercial-ShareAlike (CC BY-NC-SA)

VinayAccepted author manuscript, 1.01 MBLicence: Creative Commons: Attribution (CC-BY)
JResMedSci27157-4883051_133350Final published version, 2.18 MBLicence: Creative Commons: Attribution-NonCommercial-ShareAlike (CC BY-NC-SA)

Cite this

Chamola, V., Mohammadi, R., Nair, H., Goyal, A., Patel, A., Hassija, V., Bassetti, M., Narang, P., Paredes, R., Santos, J. R., Hashemi, S. J., Sani, M. P., Shirani, K., Alijani, N., Abtahi Naeini, B., Pourazizi, M., Abtahi, S. H., Khorvash, F., Khanjari, M., & Ahmadikia, K. (2022). COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic. Journal of Research in Medical Sciences, 27, 57. Article 57. https://doi.org/10.4103/jrms.jrms_1090_21

@article{916d4ae1e94349fd8171b015a9080ab8,

title = "COVID-19 Associated Mucormycosis:: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic",

abstract = "At a time when the COVID-19{\textquoteright}s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.",

author = "Vinay Chamola and Rasoul Mohammadi and Harish Nair and Adit Goyal and Aarya Patel and Vikas Hassija and Matteo Bassetti and Pratik Narang and Roger Paredes and Santos, \{Jose R\} and Hashemi, \{Seyed Jamal\} and Sani, \{Mahnaz Pejman\} and Kiana Shirani and Neda Alijani and \{Abtahi Naeini\}, Bahareh and Mohsen Pourazizi and Abtahi, \{Seyed Hamidreza\} and Farzin Khorvash and Mahdi Khanjari and Kazem Ahmadikia",

note = "Copyright: {\textcopyright} 2022 Journal of Research in Medical Sciences.",

year = "2022",

month = jul,

day = "29",

doi = "10.4103/jrms.jrms\_1090\_21",

language = "English",

volume = "27",

pages = "57",

journal = "Journal of Research in Medical Sciences",

issn = "1735-7136",

publisher = "Wolters Kluwer Medknow Publications",

}

Chamola, V, Mohammadi, R, Nair, H, Goyal, A, Patel, A, Hassija, V, Bassetti, M, Narang, P, Paredes, R, Santos, JR, Hashemi, SJ, Sani, MP, Shirani, K, Alijani, N, Abtahi Naeini, B, Pourazizi, M, Abtahi, SH, Khorvash, F, Khanjari, M & Ahmadikia, K 2022, 'COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic', Journal of Research in Medical Sciences, vol. 27, 57, pp. 57. https://doi.org/10.4103/jrms.jrms_1090_21

TY - JOUR

T1 - COVID-19 Associated Mucormycosis:

T2 - A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic

AU - Chamola, Vinay

AU - Mohammadi, Rasoul

AU - Nair, Harish

AU - Goyal, Adit

AU - Patel, Aarya

AU - Hassija, Vikas

AU - Bassetti, Matteo

AU - Narang, Pratik

AU - Paredes, Roger

AU - Santos, Jose R

AU - Hashemi, Seyed Jamal

AU - Sani, Mahnaz Pejman

AU - Shirani, Kiana

AU - Alijani, Neda

AU - Abtahi Naeini, Bahareh

AU - Pourazizi, Mohsen

AU - Abtahi, Seyed Hamidreza

AU - Khorvash, Farzin

AU - Khanjari, Mahdi

AU - Ahmadikia, Kazem

PY - 2022/7/29

Y1 - 2022/7/29

N2 - At a time when the COVID-19’s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.

AB - At a time when the COVID-19’s second wave is still picking up in countries like India, a number of reports describe the potential association with rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.

U2 - 10.4103/jrms.jrms_1090_21

DO - 10.4103/jrms.jrms_1090_21

M3 - Article

C2 - 36092491

SN - 1735-7136

VL - 27

SP - 57

JO - Journal of Research in Medical Sciences

JF - Journal of Research in Medical Sciences

M1 - 57

ER -

COVID-19 Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in 3 Era of COVID-19 Pandemic

Abstract

Access to Document

Fingerprint

Cite this